Last reviewed · How we verify

NCT05465304

Effect of Azithromycin in Preventing Premature Labour

Completed Last updated 17 May 2023
What this trial tests

trial testing Azithromycin in Pregnant With Complication in 200 participants. Completed in 30 April 2022.

Timeline
1 October 2021
Primary endpoint
1 April 2022
30 April 2022

Quick facts

Lead sponsorBeni-Suef University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment200
Start date1 October 2021
Primary completion1 April 2022
Estimated completion30 April 2022
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Beni-Suef University

Who can join

Adults 18 to 32, female only, with Pregnant With Complication. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a prospective observational case controlled study. The control group will include pregnant women, having intact membranes and are at risk of or in preterm labour, administrating the standard treatments for prolongation of pregnancy. The test group will involve pregnant women, having intact membranes and are at risk of or in preterm labour, administrating the standard treatments for prolongation of pregnancy plus azithromycin

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Azithromycin

Trials testing the same drug.

Other recruiting trials for Pregnant With Complication

Currently open trials in the same condition.

Other Beni-Suef University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05465304.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing